Yukitoshi Satoh Selected Research

Yukitoshi Satoh Research Topics

Disease

34	Neoplasms (Cancer) 01/2022 - 02/2005
24	Adenocarcinoma of Lung 01/2022 - 04/2004
20	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 02/2022 - 12/2005
19	Lung Neoplasms (Lung Cancer) 01/2021 - 01/2008
16	Adenocarcinoma 01/2022 - 04/2004
12	Carcinoma (Carcinomatosis) 01/2019 - 12/2007
11	Neoplasm Metastasis (Metastasis) 01/2019 - 02/2003
5	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2015 - 01/2008
5	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 06/2012 - 03/2008
4	Thymoma (Thymic Carcinoma) 01/2021 - 11/2009
3	Lymphatic Metastasis 01/2022 - 04/2011
3	Hemorrhage 09/2020 - 11/2013
3	Small Cell Carcinoma 01/2015 - 01/2008
2	Postoperative Hemorrhage 04/2020 - 03/2018
2	Inappropriate ADH Syndrome (SIADH) 01/2019 - 11/2009
2	Neuroblastoma 01/2019 - 11/2009
2	Colorectal Neoplasms (Colorectal Cancer) 08/2017 - 05/2005
2	Meningioma (Meningiomas) 01/2017 - 03/2010
2	Hematoma 01/2017 - 11/2013
2	Lewis Lung Carcinoma 02/2014 - 12/2009
1	Lymphoma (Lymphomas) 05/2020
1	Fibrosis (Cirrhosis) 09/2019
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 09/2019
1	Empyema 01/2019
1	Esophageal Neoplasms (Esophageal Cancer) 06/2018
1	Myasthenia Gravis 03/2018

Drug/Important Bio-Agent (IBA)

17	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2008
9	ErbB Receptors (EGF Receptor)IBA 01/2022 - 06/2007
6	Biological ProductsIBA 11/2019 - 01/2006
5	Cisplatin (Platino)FDA LinkGeneric 01/2020 - 02/2005
4	PlatinumIBA 01/2020 - 01/2011
4	AutoantibodiesIBA 01/2020 - 06/2012
4	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 09/2019 - 10/2008
4	Formaldehyde (Formol)FDA Link 12/2018 - 02/2010
4	Monoclonal AntibodiesIBA 04/2018 - 07/2010
3	Biomarkers (Surrogate Marker)IBA 01/2020 - 04/2010
3	Anaplastic Lymphoma KinaseIBA 01/2019 - 01/2008
3	Indicators and Reagents (Reagents)IBA 04/2018 - 01/2007
3	AntigensIBA 04/2018 - 01/2012
3	VimentinIBA 01/2018 - 04/2015
3	Carcinoembryonic AntigenIBA 08/2017 - 10/2008
3	NestinIBA 01/2017 - 04/2011
3	Messenger RNA (mRNA)IBA 12/2012 - 01/2008
3	Phosphotransferases (Kinase)IBA 02/2012 - 10/2008
3	ParaffinIBA 12/2011 - 02/2010
2	DNA (Deoxyribonucleic Acid)IBA 03/2021 - 12/2018
2	Deoxyglucose (2 Deoxy D glucose)IBA 01/2021 - 01/2021
2	Vasopressins (Vasopressin)IBA 01/2019 - 11/2009
2	SolutionsIBA 12/2018 - 02/2014
2	Cadherins (E-Cadherin)IBA 01/2018 - 01/2017
2	Tumor Biomarkers (Tumor Markers)IBA 01/2018 - 12/2011
2	Tyrosine Kinase InhibitorsIBA 01/2017 - 11/2011
2	RNA (Ribonucleic Acid)IBA 01/2017 - 10/2008
2	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 02/2014 - 12/2009
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 02/2014 - 12/2009
2	AntibodiesIBA 06/2012 - 05/2005
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2012 - 12/2009
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 02/2012 - 10/2010
2	Irinotecan (Camptosar)FDA LinkGeneric 11/2010 - 03/2008
2	Protein Isoforms (Isoforms)IBA 05/2009 - 10/2008
2	Gemcitabine FDA Link 03/2008 - 02/2005
1	Galectin 3 (LGALS3)IBA 01/2021
1	Glucose (Dextrose)FDA LinkGeneric 01/2021
1	nafamostatIBA 09/2020
1	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 05/2020
1	Protein Kinases (Protein Kinase)IBA 05/2020
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 01/2020
1	Small Interfering RNA (siRNA)IBA 11/2019
1	indium-bleomycinIBA 09/2019
1	Collagen Type I (Type I Collagen)IBA 09/2019
1	Transforming Growth Factors (Transforming Growth Factor)IBA 09/2019
1	Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA 09/2019
1	MucinsIBA 07/2019
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2019
1	SuspensionsIBA 01/2019
1	Oxidoreductases (Dehydrogenase)IBA 01/2019
1	A-Form DNA (A-DNA)IBA 12/2018
1	Basigin (Extracellular Matrix Metalloproteinase Inducer (EMMPRIN))IBA 04/2018
1	Glycoproteins (Glycoprotein)IBA 04/2018
1	Prednisone (Sone)FDA LinkGeneric 03/2018
1	C-Reactive ProteinIBA 03/2018
1	Cholinergic ReceptorsIBA 03/2018

Therapy/Procedure

6	Drug Therapy (Chemotherapy) 11/2020 - 02/2005
5	Adjuvant Chemotherapy 01/2020 - 02/2005
4	Therapeutics 01/2022 - 11/2011
4	Lymph Node Excision (Lymph Node Dissection) 01/2022 - 05/2007
4	Thymectomy 01/2021 - 11/2009
3	Operative Surgical Procedures 02/2022 - 12/2018
3	Length of Stay 04/2020 - 05/2013
2	Aftercare (After-Treatment) 01/2022 - 11/2020
2	Immunotherapy 01/2018 - 01/2017
2	Thoracotomy 11/2013 - 05/2013
2	Molecular Targeted Therapy 02/2012 - 11/2011
1	Renal Dialysis (Hemodialysis) 09/2020
1	Operative Time 04/2020
1	Robotic Surgical Procedures 04/2020
1	Esophagectomy 06/2018
1	Sternotomy 03/2018
1	Drug Tapering 03/2018
1	Activities of Daily Living (ADL) 03/2018